Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
THE DELHI High Court on Monday referred six drug patent cases to the Intellectual Property Appellate Board (IPAB), the apex government body to hear such disputes. This could set a precedent for all future appeals regarding `pre-grant
In a breakthrough in research for HIV treatment, scientists on Sunday claimed to have deciphered the three-dimensional structure of an enzyme responsible for propagating the virus in a body. The design of enzyme
The antibiotic industry boomed during the 1950s. The wonder drugs were fed to human beings and animals alike. They slowly permeated the environment—factory effluents seeped into groundwater; manure and sewage contaminated the soil. Microbes adapted to the changing environment by mutating, quickly. They entered the food chain and ended in …
By opening up its database of potential malaria drugs, GlaxoSmithKline has blazed a path that other pharmaceutical companies should follow. (Editorial)
At a hearing here at the Council of Europe, a European Union human rights watchdog, the World Health Organisation (WHO) denied on Tuesday that it was unduly influenced by drug companies to exaggerate the dangers of the H1N1 flu virus. Pharmaceutical firms picked up multi-million dollar vaccination contracts when the …
The turf war between the pharmaceutical industry and Drug Controller General of India (DCGI) is set to intensify after sources close to DCGI confirmed on Monday that the drug controller will soon be approaching the Supreme Court over the issue of centralising power to grant Certificate of Pharmaceutical Products (CoPP)
Any sufficiently advanced technology is indistinguishable from magic, Arthur C. Clarke once wrote. So it is with stem cells and their almost miraculous potential to save our lives. Stem cells are so tiny that it would take a million of them clustered together to form a pin head. Yet as …
For the first time ever, India has issued a demarche to China on an economic issue. The stern diplomatic protest follows the dissatisfaction over the lack of specific commitments offered by the Chinese government to facilitate export of Indian goods and services to the latter, which are increasingly coming under …
Even as questions are raised about the efficacy of the H1N1 vaccine, India has given leading French pharmaceutical company Sanofi Pasteur permission to start trials from Wednesday. While the trials will take about three weeks, the single dose vaccine will be available from the second week of February.
To Be Tested On 100 Volunteers; In April, Local Version At Rs 80 Kounteya Sinha | TNN New Delhi: Clinical trials of the first H1N1 vaccine to be used on Indians from mid-February will start on Wednesday. Three medical institutes in Delhi, Chandigarh and Pune will test the H1N1 vaccine …
Amiti Sen & Khomba singh NEW DELHI THE European Union has assured India that it will suitably modify its Customs regulation or its application by this month-end to ensure that generics shipped from India do not get detained at its ports, indicating a possible end to this long-standing irritant to …
Concerned over the increasing use of animals for clinical trials, Environment Minister Jairam Ramesh today advocated alternatives to reduce the practice. He said recent trend shows that the use of primates in experimentation was on an upward climb.
